Stock analysts at DA Davidson began coverage on shares of Imperva (NASDAQ:IMPV) in a research report issued to clients and investors on Tuesday, MarketBeat reports. The firm set a “buy” rating and a $56.00 price target on the software maker’s stock. DA Davidson’s price objective would suggest a potential upside of 22.94% from the stock’s previous close.
A number of other analysts have also issued reports on IMPV. BidaskClub lowered Imperva from a “buy” rating to a “hold” rating in a research report on Thursday, March 29th. Evercore ISI set a $56.00 price objective on Imperva and gave the stock a “buy” rating in a research report on Friday, February 9th. Piper Jaffray raised Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 price objective on the stock in a research report on Friday, February 9th. Imperial Capital upped their price objective on Imperva from $50.00 to $55.00 and gave the stock an “outperform” rating in a research report on Friday, February 9th. Finally, ValuEngine raised Imperva from a “sell” rating to a “hold” rating in a research report on Thursday, February 15th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $53.21.
Shares of NASDAQ IMPV opened at $45.55 on Tuesday. The company has a market capitalization of $1,522.77, a price-to-earnings ratio of -162.68 and a beta of 1.67. Imperva has a 52-week low of $37.17 and a 52-week high of $52.40.
Imperva (NASDAQ:IMPV) last announced its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.13. The company had revenue of $91.10 million for the quarter, compared to analyst estimates of $91.11 million. Imperva had a negative return on equity of 3.28% and a net margin of 7.11%. The firm’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.32 earnings per share. equities research analysts expect that Imperva will post -0.17 EPS for the current year.
In related news, CRO Michael D. Mooney sold 24,454 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the completion of the transaction, the executive now owns 24,454 shares in the company, valued at $1,153,739.72. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Anthony J. Bettencourt sold 66,037 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the transaction, the director now owns 66,037 shares of the company’s stock, valued at approximately $3,102,418.26. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.
Several hedge funds have recently modified their holdings of the stock. MetLife Investment Advisors LLC acquired a new position in shares of Imperva during the fourth quarter worth $625,000. Teachers Advisors LLC grew its stake in shares of Imperva by 2.3% during the fourth quarter. Teachers Advisors LLC now owns 61,251 shares of the software maker’s stock worth $2,432,000 after purchasing an additional 1,381 shares in the last quarter. HBK Investments L P acquired a new position in shares of Imperva during the fourth quarter worth $1,171,000. Two Sigma Investments LP grew its stake in shares of Imperva by 92.2% during the fourth quarter. Two Sigma Investments LP now owns 308,711 shares of the software maker’s stock worth $12,256,000 after purchasing an additional 148,077 shares in the last quarter. Finally, Two Sigma Advisers LP grew its stake in shares of Imperva by 11.8% during the fourth quarter. Two Sigma Advisers LP now owns 355,504 shares of the software maker’s stock worth $14,114,000 after purchasing an additional 37,400 shares in the last quarter.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/12/da-davidson-begins-coverage-on-imperva-impv.html.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.